legislation: 116-hconres-55

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
116-hconres-55 116 hconres 55 Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements. Health 2019-07-24 2019-07-24 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Burgess, Michael C. [R-TX-26] TX R B001248 0 This concurrent resolution expresses the sense of Congress that (1) the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; (2) the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; (3) the final rule by the CMS published in the Federal Register on May 10, 2019, makes substantial progress in improving drug pricing transparency; and (4) such rule should be enacted into law. 2022-11-01T13:50:26Z  

Links from other tables